AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9834926 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate formulation (RCF)
Number of subjects: 52
Study 7915963 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 14
Study 2668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard biopsy forceps
Number of subjects: 26
Study 2668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 26
Study 2668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy from different locations (second, third, fourth portions of the duodenum, ligament of Treitz, jejunum)
Number of subjects: 26
Study 2668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy from different locations
Number of subjects: 26
Study 2668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy
Number of subjects: 26
Study 326048 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin plus cephalothin
Number of subjects: 334
Study 326048 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin plus cefazolin
Number of subjects: 334
Study 326048 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin
Number of subjects: 334
Study 326048 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 334
Study 31599079 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-min step test (6MST)
Number of subjects: 35
Study 30769164 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-scan technique with selenium supplementation
Number of subjects: 0
Study 30769164 — intervention group
Group type: COMPARATOR
Intervention: Z-scan technique without selenium supplementation
Number of subjects: 0
Study 30769164 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectrophotometry technique with selenium supplementation
Number of subjects: 0
Study 30769164 — intervention group
Group type: COMPARATOR
Intervention: Spectrophotometry technique without selenium supplementation
Number of subjects: 0
Study 28835713 — intervention group
Group type: EXPERIMENTAL
Intervention: NγLR > 103.6
Number of subjects: 724
Study 28835713 — intervention group
Group type: COMPARATOR
Intervention: NγLR ≤ 103.6
Number of subjects: 724
Study 24667592 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v (5 × 10 colony forming units daily)
Number of subjects: 0
Study 24667592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24667592 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v
Number of subjects: 0
Study 23218847 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus web-delivered BAI
Number of subjects: 167
Study 23218847 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 167
Study 21516002 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health promotion project for garlic farmers (12 weeks)
Number of subjects: 72
Study 18083636 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 6241
Study 16966226 — intervention group
Group type: EXPERIMENTAL
Intervention: Creativity enhancement intervention
Number of subjects: 0
Study 12767649 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioventricular junction ablation and pacing (AVJAP)
Number of subjects: 99
Study 10697086 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial support program during early rehabilitation
Number of subjects: 151
Study 9088734 — intervention group
Group type: EXPERIMENTAL
Intervention: levobunolol HCl 0.5%
Number of subjects: 15
Study 9088734 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 8251030 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms/kg)
Number of subjects: 17
Study 8251030 — intervention group
Group type: COMPARATOR
Intervention: Conventional antiemetics
Number of subjects: 17
Study 3810557 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH 1 (1000, 1500, 2500 i.u.)
Number of subjects: 24
Study 3810557 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH 1 (2500 i.u.)
Number of subjects: 24
Study 3810557 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH 2 (2500 i.u.)
Number of subjects: 24
Study 3810557 — intervention group
Group type: COMPARATOR
Intervention: UFH (5000 i.u.)
Number of subjects: 24
Study 3810557 — intervention group
Group type: EXPERIMENTAL
Intervention: All heparins tested
Number of subjects: 24
Study 28314876 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPC) with three cycles of 5-min cuff inflation followed by 5-min deflation to the upper arm
Number of subjects: 78
Study 28314876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 78
Study 28314876 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPC)
Number of subjects: 78
Study 27706045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 IU IV daily for three days)
Number of subjects: 35
Study 27706045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 27706045 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 35
Study 25342049 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal 2 (meal 1 mixed with 9 g guar)
Number of subjects: 12
Study 25342049 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal 3 (meal 1 divided into 12 equal portions over 60 min)
Number of subjects: 12
Study 25342049 — intervention group
Group type: COMPARATOR
Intervention: Meal 1 (control meal)
Number of subjects: 12
Study 23833281 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological awareness
Number of subjects: 304
Study 23833281 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthographic awareness
Number of subjects: 304
Study 23833281 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphological awareness
Number of subjects: 304
Study 23833281 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive vocabulary
Number of subjects: 304
Study 23833281 — intervention group
Group type: EXPERIMENTAL
Intervention: RtI status (Tiers 1, 2, & 3)
Number of subjects: 304
Study 20547947 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 36
Study 18212755 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine 1200 mg/m² on days 1 and 8 every 3 weeks for three courses followed by docetaxel 37.5 mg/m² on days 1 and 8 every 3 weeks
Number of subjects: 56
Study 18212755 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine followed by docetaxel
Number of subjects: 56
Study 16856643 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management classes
Number of subjects: 0
Study 16856643 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 0
Study 12696991 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 12696991 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study 10920611 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone treatment
Number of subjects: 132
Study 10920611 — intervention group
Group type: COMPARATOR
Intervention: Unjustly untreated group
Number of subjects: 132
Study 8751518 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte depletion (n = 20)
Number of subjects: 30
Study 8751518 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 30
Study 1434659 — intervention group
Group type: EXPERIMENTAL
Intervention: Early drain removal after 3 days postmastectomy
Number of subjects: 0
Study 1434659 — intervention group
Group type: COMPARATOR
Intervention: Standard drain removal after 6 days postmastectomy
Number of subjects: 0
Study 4039588 — intervention group
Group type: EXPERIMENTAL
Intervention: Neobiphyllin (TPD) - 800 mg, infused for 20 min
Number of subjects: 10
Study 4039588 — intervention group
Group type: COMPARATOR
Intervention: Theophylline-ethylendiamine (TE) - 480 mg, short-infusion for 20 min
Number of subjects: 10
Study 30913160 — intervention group
Group type: EXPERIMENTAL
Intervention: Appendicular BFR exercise
Number of subjects: 32
Study 30913160 — intervention group
Group type: COMPARATOR
Intervention: Control exercise (CON exercise)
Number of subjects: 32
Study 27796434 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Pearls™ Acidophilus (Pearls)
Number of subjects: 12
Study 27796434 — intervention group
Group type: COMPARATOR
Intervention: Conventional hard‐shelled gelatin capsule
Number of subjects: 12
Study 25601917 — intervention group
Group type: COMPARATOR
Intervention: No VTE prophylaxis (Group A)
Number of subjects: 2196
Study 25601917 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low-dose unfractionated heparin (LDUH) 125 U/kg per day in three divided doses (Group B)
Number of subjects: 2196
Study 25601917 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) 6000 IU once a day (Group C)
Number of subjects: 2196
Study 25601917 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH 4000 IU twice daily (Group D)
Number of subjects: 2196
Study 23571688 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate full weight-bearing for 3 months
Number of subjects: 39
Study 23571688 — intervention group
Group type: COMPARATOR
Intervention: Partial weight-bearing for 3 months
Number of subjects: 39
Study 23571688 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups at 5 years
Number of subjects: 39
Study 20705373 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA 1 g daily
Number of subjects: 40
Study 20705373 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 40
Study 19389558 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1058
Study 19389558 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1058
Study 16643226 — intervention group
Group type: EXPERIMENTAL
Intervention: LCT/MCT propofol
Number of subjects: 50
Study 16643226 — intervention group
Group type: COMPARATOR
Intervention: LCT propofol
Number of subjects: 50
Study 15575002 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 25
Study 15575002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11245321 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g cefotiam (study group, n=76)
Number of subjects: 146
Study 11245321 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (control group, n=70)
Number of subjects: 146
Study 9730793 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPI (beclomethasone dipropionate) 400 microgram twice daily
Number of subjects: 133
Study 9730793 — intervention group
Group type: COMPARATOR
Intervention: MDI-spacer (beclomethasone dipropionate) 400 microgram twice daily
Number of subjects: 133
Study 9730793 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPI
Number of subjects: 133
Study 9730793 — intervention group
Group type: COMPARATOR
Intervention: MDI-spacer
Number of subjects: 133
Study 9730793 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPI and MDI-spacer
Number of subjects: 133
Study 8044729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate with fluphenazine HCl i.m.
Number of subjects: 0
Study 8044729 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate depot injection used alone
Number of subjects: 0
Study 3155318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 12
Study 3155318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study 3155318 — intervention group
Group type: COMPARATOR
Intervention: Nicardipine and Nifedipine
Number of subjects: 12
Study 30137607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction for Breast Cancer (MBSR[BC]) program
Number of subjects: 185
Study 30137607 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 185
Study 27773708 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-targeted intervention to increase LARC access
Number of subjects: 1500
Study 27773708 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1500
Study 26158894 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 23
Study 26158894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 23849501 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/day
Number of subjects: 0
Study 23849501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22416440 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus ivabradin
Number of subjects: 49
Study 22416440 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 49
Study 19453578 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid analgesia
Number of subjects: 4
Study 19453578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 16735696 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon‐alpha (IFN‐alpha) and ribavirin
Number of subjects: 20
Study 15519705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib vaccination (1 dose)
Number of subjects: 389
Study 15519705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib vaccination (2 doses)
Number of subjects: 389
Study 15519705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib vaccination (3 doses)
Number of subjects: 389
Study 10938566 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantum Companion
Number of subjects: 34
Study 10938566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 9300509 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychological intervention based on cognitive behavioural principles, including individualized information and discussion session by a specially trained cardiac nurse, handout, cassette providing information and advice, and telephone follow-up.
Number of subjects: 0
Study 9300509 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified, but implied to be patients receiving standard care without the intervention.
Number of subjects: 0
Study 10128359 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) administered in PVC containers
Number of subjects: 20
Study 10128359 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (NTG) administered in glass containers
Number of subjects: 20
Study 3310905 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prochlorperazine, metoclopramide and dexamethasone
Number of subjects: 40
Study 3310905 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide and dexamethasone
Number of subjects: 40
Study 3310905 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide and dexamethasone on days 2‐7
Number of subjects: 40
Study 30104307 — intervention group
Group type: EXPERIMENTAL
Intervention: 10TT intervention (habit-based advice for weight control)
Number of subjects: 537
Study 30104307 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study 30104307 — intervention group
Group type: COMPARATOR
Intervention: 10TT intervention vs usual care
Number of subjects: 537
Study 26840331 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (200 mg/day)
Number of subjects: 19
Study 26840331 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 mg/day)
Number of subjects: 19
Study 24432995 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianqi capsule for 12 months
Number of subjects: 420
Study 24432995 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 420
Study 23899039 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-monthly monitoring
Number of subjects: 2215
Study 23899039 — intervention group
Group type: COMPARATOR
Intervention: Six-monthly monitoring
Number of subjects: 2215
Study 23899039 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference group (self-selected monitoring frequency)
Number of subjects: 2215
Study 23899039 — intervention group
Group type: COMPARATOR
Intervention: Randomised patients (not preferring a specific frequency)
Number of subjects: 2215
Study 19912490 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernous injection (ICI) of alprostadil 20 microgram
Number of subjects: 60
Study 19912490 — intervention group
Group type: COMPARATOR
Intervention: Audio-visual sexual stimulation (AVSS)
Number of subjects: 60
Study 19912490 — intervention group
Group type: EXPERIMENTAL
Intervention: AVSS plus ICI
Number of subjects: 60
Study 19138002 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffractive MFIOL (Tecnis Multifocal)
Number of subjects: 100
Study 19138002 — intervention group
Group type: EXPERIMENTAL
Intervention: Refractive MFIOL (ReZoom)
Number of subjects: 100
Study 16968572 — intervention group
Group type: EXPERIMENTAL
Intervention: Travoprost 0.004% ophthalmic solution (Travatan)
Number of subjects: 62
Study 16968572 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005% (Xalatan)
Number of subjects: 62
Study 15299057 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA-M (1 field of view)
Number of subjects: 11
Study 15299057 — intervention group
Group type: EXPERIMENTAL
Intervention: SKA-S
Number of subjects: 11
Study 15299057 — intervention group
Group type: COMPARATOR
Intervention: Patlak analysis
Number of subjects: 11
Study 11228598 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% oxygen for ca. 10 min at 15 L/min by a face mask (treatment group)
Number of subjects: 41
Study 11228598 — intervention group
Group type: COMPARATOR
Intervention: No oxygen supplementation (control group)
Number of subjects: 41
Study 9310010 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg isoniazid (INH)
Number of subjects: 105
Study 9310010 — intervention group
Group type: EXPERIMENTAL
Intervention: 18.75 mg isoniazid (INH)
Number of subjects: 105
Study 9310010 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg isoniazid (INH)
Number of subjects: 105
Study 9310010 — intervention group
Group type: COMPARATOR
Intervention: rifampin
Number of subjects: 105
Study 8242574 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-part structured pain education program
Number of subjects: 40
Study 8242574 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 40
Study 3749007 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI)
Number of subjects: 0
Study 3749007 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 3749007 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 0
Study 3749007 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum thiocyanate
Number of subjects: 0
Study 3749007 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on the Framingham Study
Number of subjects: 0
Study 3749007 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression coefficients for CHD and total mortality endpoints
Number of subjects: 0
Study 30950208 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 40 mg/d
Number of subjects: 0
Study 30950208 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/d
Number of subjects: 0
Study 30950208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26984227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary patterns in Puerto Rican breast cancer survivors
Number of subjects: 45
Study 26984227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary patterns in Mexican-American breast cancer survivors
Number of subjects: 45
Study 26984227 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH-style diet adherence score
Number of subjects: 45
Study 26984227 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight/obesity prevalence
Number of subjects: 45
Study 25847979 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (OMT)
Number of subjects: 1800
Study 25847979 — intervention group
Group type: COMPARATOR
Intervention: Revascularization strategy (CABG)
Number of subjects: 1800
Study 25847979 — intervention group
Group type: COMPARATOR
Intervention: Revascularization strategy (Percutaneous Coronary Intervention)
Number of subjects: 1800
Study 23691692 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate maintenance infusion of 2 g/hour
Number of subjects: 60
Study 23691692 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate maintenance infusion of 1 g/hour
Number of subjects: 60
Study 21910336 — intervention group
Group type: EXPERIMENTAL
Intervention: Xunxi No. 1 intervention with radiotherapy for 20 days
Number of subjects: 80
Study 21910336 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 80
Study 19773098 — intervention group
Group type: EXPERIMENTAL
Intervention: Vero cell culture-derived inactivated whole virus influenza A/H5N1 vaccine without aluminum hydroxide adjuvant
Number of subjects: 0
Study 19773098 — intervention group
Group type: EXPERIMENTAL
Intervention: Vero cell culture-derived inactivated whole virus influenza A/H5N1 vaccine with aluminum hydroxide adjuvant
Number of subjects: 0
Study 19773098 — intervention group
Group type: EXPERIMENTAL
Intervention: Vero cell culture-derived inactivated whole virus influenza A/H5N1 vaccine
Number of subjects: 0
Study 17522559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular aripiprazole
Number of subjects: 3
Study 17522559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular aripiprazole (second injection)
Number of subjects: 3
Study 14754783 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised benzodiazepine withdrawal program
Number of subjects: 76
Study 14754783 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for insomnia
Number of subjects: 76
Study 14754783 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised withdrawal plus cognitive behavior therapy
Number of subjects: 76
Study 14754783 — intervention group
Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 76
Study 11719664 — intervention group
Group type: EXPERIMENTAL
Intervention: urokinase plus abciximab
Number of subjects: 70
Study 11719664 — intervention group
Group type: COMPARATOR
Intervention: urokinase alone
Number of subjects: 70
Study 9117178 — intervention group
Group type: EXPERIMENTAL
Intervention: Living food, a form of uncooked vegan diet rich in lactobacilli
Number of subjects: 43